40% of AFib patients have ‘silent’ brain damage that could explain predisposition to dementia

More than 40 percent of patients with atrial fibrillation (AFib) but no record of stroke or transient ischemic attack have previously unknown, “silent” brain damage, according to research presented this week at the European Society of Cardiology Congress (ESC) in Munich. The findings might explain why those with AFib also face an increased risk of cognitive dysfunction and dementia.

Prevencio Announces Data Demonstrating HART PAD™ Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients

KIRKLAND, Wash., Aug. 27, 2018 — Prevencio, Inc. today announces data demonstrating its HART PAD™ test accurately diagnoses peripheral artery disease (PAD) in diabetes mellitus (DM) patients, a patient population in which PAD prevalence has traditionally been difficult to assess.